Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters

BACKGROUND. Calcineurin inhibitors (CNIs) and steroids are strongly associated with new-onset diabetes after transplantation, worsening of pre-existing diabetes, and cardiovascular events. We assessed the benefit of conversion from CNI-based to belatacept-based immunosuppression in diabetic kidney-t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transplant Direct
Glavni autori: Terrec, Florian, Jouve, Thomas, Naciri-Bennani, Hamza, Benhamou, Pierre-Yves, Malvezzi, Paolo, Janbon, Benedicte, Giovannini, Diane, Rostaing, Lionel, Noble, Johan
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2019
Teme:
Kidney Transplantation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964931/
https://ncbi.nlm.nih.gov/pubmed/32047845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000964
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items